CymaBay Therapeutics Inc.

NASDAQ: CBAY · Real-Time Price · USD
32.48
0.01 (0.03%)
At close: Mar 21, 2024, 8:00 PM

CymaBay Therapeutics Revenue

CymaBay Therapeutics reported an annual revenue of $31.07M, reflecting a 0% growth. For the quarter ending December 31, 2023, CymaBay Therapeutics generated $57K in revenue.
Revenue (ttm)
$31.07M
Revenue Growth
0%
Price / Sales Ratio
80.73
Revenue / Employee
$307.65K
Employees
101
Market Cap
3.73B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.